NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.7501
-0.0300 (-3.85%)
Jun 5, 2026, 4:00 PM EDT - Market closed
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $26.52 million as of June 5, 2026. Its market cap has decreased by -26.31% in one year.
Market Cap
26.52M
Enterprise Value
27.04M
1-Year Change
-26.31%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $26.52M, a decrease of -58.96%. That is a compound annual growth rate of -17.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 26.52M | 16.10% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 29.49M |
| Lite Strategy | 28.78M |
| Kyntra Bio | 28.37M |
| Barinthus Biotherapeutics | 27.59M |
| Tvardi Therapeutics | 27.49M |
| CervoMed | 27.22M |
| Skye Bioscience | 26.76M |
| Dyadic International | 26.38M |